Cardiff Oncology Statistics
Total Valuation
CRDF has a market cap or net worth of $100.63 million. The enterprise value is $35.44 million.
| Market Cap | 100.63M |
| Enterprise Value | 35.44M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CRDF has 44.72 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Shares Outstanding | 44.72M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 7.55% |
| Owned by Institutions (%) | 23.91% |
| Float | 41.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 164.97 |
| Forward PS | 415.40 |
| PB Ratio | 1.65 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 58.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.03.
| Current Ratio | 5.91 |
| Quick Ratio | 5.71 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.60% and return on invested capital (ROIC) is -70.43%.
| Return on Equity (ROE) | -54.60% |
| Return on Assets (ROA) | -47.10% |
| Return on Capital (ROIC) | -70.43% |
| Revenue Per Employee | $19,063 |
| Profits Per Employee | -$1.26M |
| Employee Count | 32 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.06% in the last 52 weeks. The beta is 1.94, so CRDF's price volatility has been higher than the market average.
| Beta (5Y) | 1.94 |
| 52-Week Price Change | +47.06% |
| 50-Day Moving Average | 2.83 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 37.93 |
| Average Volume (20 Days) | 841,994 |
Short Selling Information
The latest short interest is 4.22 million, so 9.44% of the outstanding shares have been sold short.
| Short Interest | 4.22M |
| Short Previous Month | 4.04M |
| Short % of Shares Out | 9.44% |
| Short % of Float | 10.21% |
| Short Ratio (days to cover) | 5.65 |
Income Statement
In the last 12 months, CRDF had revenue of $610,000 and -$40.25 million in losses. Loss per share was -$0.90.
| Revenue | 610,000 |
| Gross Profit | 610,000 |
| Operating Income | -44.29M |
| Pretax Income | -40.23M |
| Net Income | -40.25M |
| EBITDA | -39.82M |
| EBIT | -40.23M |
| Loss Per Share | -$0.90 |
Balance Sheet
The company has $67.19 million in cash and $2.00 million in debt, giving a net cash position of $65.19 million or $1.46 per share.
| Cash & Cash Equivalents | 67.19M |
| Total Debt | 2.00M |
| Net Cash | 65.19M |
| Net Cash Per Share | $1.46 |
| Equity (Book Value) | 60.89M |
| Book Value Per Share | 1.36 |
| Working Capital | 58.15M |
Cash Flow
In the last 12 months, operating cash flow was -$29.97 million and capital expenditures -$654,000, giving a free cash flow of -$30.62 million.
| Operating Cash Flow | -29.97M |
| Capital Expenditures | -654,000 |
| Free Cash Flow | -30.62M |
| FCF Per Share | -$0.69 |
Margins
Gross margin is 100.00%, with operating and profit margins of -7,261.15% and -6,598.85%.
| Gross Margin | 100.00% |
| Operating Margin | -7,261.15% |
| Pretax Margin | -6,594.92% |
| Profit Margin | -6,598.85% |
| EBITDA Margin | -6,527.70% |
| EBIT Margin | -6,594.92% |
| FCF Margin | -5,020.00% |
Dividends & Yields
CRDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | -0.00% |
| Earnings Yield | -40.00% |
| FCF Yield | -30.43% |
Analyst Forecast
The average price target for CRDF is $10.50, which is 366.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.50 |
| Price Target Difference | 366.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | -26.88% |
| EPS Growth Forecast (5Y) | 19.80% |
Stock Splits
The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.
| Last Split Date | Feb 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
CRDF has an Altman Z-Score of -2.84 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.84 |
| Piotroski F-Score | 3 |